Teva Pharmaceutical Industries annual dividends paid
2007
2008
2009
2010
2011
2012
2013
2016
2017
2018
Teva Pharmaceutical Industries Dividends Paid Growth & History (TEVA)
Teva Pharmaceutical Industries paid $12.0M in dividends during fiscal 2018.
View full Teva Pharmaceutical Industries company overviewTeva Pharmaceutical Industries annual dividends paid history
| Fiscal year | Period ended | Dividends paid | Change | Growth |
|---|---|---|---|---|
| 2018 | 2018-12-31 | $12.0M | −$889.0M | −98.67% |
| 2017 | 2017-12-31 | $901.0M | −$402.0M | −30.85% |
| 2016 | 2016-12-31 | $1.30B | — | — |
| 2013 | 2013-12-31 | $1.09B | $234.0M | +27.37% |
| 2012 | 2012-12-31 | $855.0M | $55.0M | +6.88% |
| 2011 | 2011-12-31 | $800.0M | $132.0M | +19.76% |
| 2010 | 2010-12-31 | $668.0M | $139.0M | +26.28% |
| 2009 | 2009-12-31 | $529.0M | $142.0M | +36.69% |
| 2008 | 2008-12-31 | $387.0M | $88.0M | +29.43% |
| 2007 | 2007-12-31 | $299.0M | — | — |
Teva Pharmaceutical Industries quarterly dividends paid
Q1.08
Q2.08
Q3.08
Q4.08
Q1.09
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q1.14
Q2.14
Q3.14
Q1.16
Q2.16
Q3.16
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
| Fiscal quarter | Period ended | Dividends paid | Change | YoY change |
|---|---|---|---|---|
| Q4 2018 | 2018-12-31 | $0 | −$87.0M | — |
| Q3 2018 | 2018-09-30 | $0 | −$123.0M | — |
| Q2 2018 | 2018-06-30 | $0 | −$345.0M | — |
| Q1 2018 | 2018-03-31 | $12.0M | −$334.0M | −96.53% |
| Q4 2017 | 2017-12-31 | $87.0M | −$259.0M | −74.86% |
| Q3 2017 | 2017-09-30 | $123.0M | −$217.0M | −63.82% |
| Q2 2017 | 2017-06-30 | $345.0M | $35.0M | +11.29% |
| Q1 2017 | 2017-03-31 | $346.0M | $39.0M | +12.70% |
| Q4 2016 | 2016-12-31 | $346.0M | — | — |
| Q3 2016 · Sep 30 | 2016-09-30 | $340.0M | $53.0M | +18.47% |
| Q2 2016 · Jun 30 | 2016-06-30 | $310.0M | $22.0M | +7.64% |
| Q1 2016 · Mar 31 | 2016-03-31 | $307.0M | $17.0M | +5.86% |
| Q3 2016 · Sep 30 | 2015-09-30 | $287.0M | −$7.0M | −2.38% |
| Q2 2016 · Jun 30 | 2015-06-30 | $288.0M | −$11.0M | −3.68% |
| Q1 2016 · Mar 31 | 2015-03-31 | $290.0M | −$1.0M | −0.34% |
| Q3 2014 | 2014-09-30 | $294.0M | $30.0M | +11.36% |
| Q2 2014 | 2014-06-30 | $299.0M | $31.0M | +11.57% |
| Q1 2014 | 2014-03-31 | $291.0M | $10.0M | +3.56% |
| Q3 2013 | 2013-09-30 | $264.0M | $27.0M | +11.39% |
| Q2 2013 | 2013-06-30 | $268.0M | $38.0M | +16.52% |
| Q1 2013 · Mar 31 | 2013-03-31 | $281.0M | $107.0M | +61.49% |
| Q4 2012 | 2012-12-31 | $214.0M | $24.0M | +12.63% |
| Q3 2012 | 2012-09-30 | $237.0M | $33.0M | +16.18% |
| Q2 2012 | 2012-06-30 | $230.0M | $27.0M | +13.30% |
| Q1 2012 | 2012-03-31 | $174.0M | −$29.0M | −14.29% |
| Q4 2011 | 2011-12-31 | $190.0M | $18.0M | +10.47% |
| Q3 2011 | 2011-09-30 | $204.0M | $37.0M | +22.16% |
| Q2 2011 | 2011-06-30 | $203.0M | $39.0M | +23.78% |
| Q1 2011 | 2011-03-31 | $203.0M | $38.0M | +23.03% |
| Q4 2010 | 2010-12-31 | $172.0M | $30.0M | +21.13% |
| Q3 2010 | 2010-09-30 | $167.0M | $41.0M | +32.54% |
| Q2 2010 | 2010-06-30 | $164.0M | $30.0M | +22.39% |
| Q1 2010 | 2010-03-31 | $165.0M | $38.0M | +29.92% |
| Q4 2009 | 2009-12-31 | $142.0M | $53.0M | +59.55% |
| Q3 2009 | 2009-09-30 | $126.0M | $29.0M | +29.90% |
| Q2 2009 | 2009-06-30 | $134.0M | $28.0M | +26.42% |
| Q1 2009 | 2009-03-31 | $127.0M | $32.0M | +33.68% |
| Q4 2008 | 2008-12-31 | $89.0M | — | — |
| Q3 2008 | 2008-09-30 | $97.0M | — | — |
| Q2 2008 | 2008-06-30 | $106.0M | — | — |
| Q1 2008 | 2008-03-31 | $95.0M | — | — |
Teva Pharmaceutical Industries dividends paid trends
Over the last five fiscal years, Teva Pharmaceutical Industries's dividends paid decreased from $1.09B to $12.0M, a change of −$1.08B. The latest reported quarter, Q4 2018, shows $0.
About the metric
What dividends paid mean
Dividends paid are cash distributions made to shareholders. The history shows the company’s aggregate cash outflow for dividends, not the dividend per share, dividend yield, or the date an investor receives a payment.
Calculation and source
Reported cash dividends paid
TickerStat standardizes cash dividends paid to common or ordinary shareholders from official cash-flow filings. Reported zero-dividend periods remain zero and are not treated as missing data. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Teva Pharmaceutical Industries source filings ↗